| Jonathan A Lazarini, MD | |
|
1500 S Main St, Fort Worth, TX 76104-4917 | |
| (903) 353-2265 | |
| Not Available |
| Full Name | Jonathan A Lazarini |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 1500 S Main St, Fort Worth, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003102245 | NPI | - | NPPES |
| Entity Name | Concord Medical Group Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083630610 PECOS PAC ID: 0446296818 Enrollment ID: O20050707000531 |
News Archive
Those 25-year-olds who are overweight now but think they will be fine as long as they lose weight eventually might need to reconsider. A study appearing online in the Journal of Adolescent Health finds that people who are overweight during young adulthood are likely to die earlier than others.
Peptilogics, a development stage company utilizing its innovative peptide platform to treat multidrug-resistant bacterial infections, today announced it recently held a pre-Investigational New Drug (pre-IND) meeting with the U.S. Food and Drug Administration to discuss the regulatory pathway for the development of PLG0206 for the treatment of prosthetic joint infections.
Dey Pharma L.P., a subsidiary of Mylan Inc., today announced that the U.S. Patent and Trademark Office intends to reissue both of the patents related to Perforomist Inhalation Solution 20 mcg/2mL vial that had been placed into reexamination by Sepracor, now known as Sunovion Pharmaceuticals.
Autoantibodies are present many years before symptom onset in patients with primary Sjögren syndrome, an autoimmune disease, according to a Research Letter published in the November 6 issue of JAMA.
› Verified 7 days ago
| Entity Name | Concord Medical Group Of Texas Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750790762 PECOS PAC ID: 7810117223 Enrollment ID: O20141007002567 |
News Archive
Those 25-year-olds who are overweight now but think they will be fine as long as they lose weight eventually might need to reconsider. A study appearing online in the Journal of Adolescent Health finds that people who are overweight during young adulthood are likely to die earlier than others.
Peptilogics, a development stage company utilizing its innovative peptide platform to treat multidrug-resistant bacterial infections, today announced it recently held a pre-Investigational New Drug (pre-IND) meeting with the U.S. Food and Drug Administration to discuss the regulatory pathway for the development of PLG0206 for the treatment of prosthetic joint infections.
Dey Pharma L.P., a subsidiary of Mylan Inc., today announced that the U.S. Patent and Trademark Office intends to reissue both of the patents related to Perforomist Inhalation Solution 20 mcg/2mL vial that had been placed into reexamination by Sepracor, now known as Sunovion Pharmaceuticals.
Autoantibodies are present many years before symptom onset in patients with primary Sjögren syndrome, an autoimmune disease, according to a Research Letter published in the November 6 issue of JAMA.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jonathan A Lazarini, MD 8644 Fernhill Dr, Fort Worth, TX 76123-4015 Ph: () - | Jonathan A Lazarini, MD 1500 S Main St, Fort Worth, TX 76104-4917 Ph: (903) 353-2265 |
News Archive
Those 25-year-olds who are overweight now but think they will be fine as long as they lose weight eventually might need to reconsider. A study appearing online in the Journal of Adolescent Health finds that people who are overweight during young adulthood are likely to die earlier than others.
Peptilogics, a development stage company utilizing its innovative peptide platform to treat multidrug-resistant bacterial infections, today announced it recently held a pre-Investigational New Drug (pre-IND) meeting with the U.S. Food and Drug Administration to discuss the regulatory pathway for the development of PLG0206 for the treatment of prosthetic joint infections.
Dey Pharma L.P., a subsidiary of Mylan Inc., today announced that the U.S. Patent and Trademark Office intends to reissue both of the patents related to Perforomist Inhalation Solution 20 mcg/2mL vial that had been placed into reexamination by Sepracor, now known as Sunovion Pharmaceuticals.
Autoantibodies are present many years before symptom onset in patients with primary Sjögren syndrome, an autoimmune disease, according to a Research Letter published in the November 6 issue of JAMA.
› Verified 7 days ago
Mrs. Adeline Galvez, Family Medicine Medicare: Medicare Enrolled Practice Location: 1300 W Terrell Ave Ste 270, Fort Worth, TX 76104 Phone: 817-250-4987 | |
Fomundam Newnton Mbuh, NP Family Medicine Medicare: Medicare Enrolled Practice Location: 4759 South Fwy Ste 101, Fort Worth, TX 76115 Phone: 817-382-0005 | |
Dr. Joane Baumer, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1500 S Main St, Family Medicine Center, Fort Worth, TX 76104 Phone: 817-335-1034 | |
Evelyn Tobias-merrill, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2825 Stadium Dr, Fort Worth, TX 76109 Phone: 817-257-7940 | |
Dr. Michael David Carletti, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 855 Montgomery St, Fort Worth, TX 76107 Phone: 817-735-0278 | |
Bhavna Nitin Tanna, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 601 W Terrell Ave, Fort Worth, TX 76104 Phone: 817-702-2977 |